TSS
MDCO

Two Sigma Securities’s Medicines Co MDCO Stock Holding History

Two Sigma Securities’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-25,542
Closed -$937K – 3187
2018
Q2 		$937K Buy
25,542
+14,760
+137% +$480K ﹤0.01% 1384
2018
Q1 		$355K Buy
+10,782
New +$337K ﹤0.01% 1892

Other funds holding MDCO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Two Sigma Securities's MDCO Position: Q3 2018 in Review

Two Sigma Securities sold out of Medicines Co (MDCO) in Q3 2018, closing a stake of 25,542 shares — an estimated $937K sold.

Two Sigma Securities first reported a position in MDCO in Q1 2018 and held it in 2 quarters. The position peaked at $937K in Q2 2018. 184 funds tracked by Wall St. Rank hold MDCO as of Q3 2018.

  • Two Sigma Securities reported no remaining Medicines Co position as of Q3 2018 after selling out during the quarter.
  • Two Sigma Securities sold 25,542 Medicines Co shares in Q3 2018, an estimated $937K.
  • Two Sigma Securities first reported a position in Medicines Co in Q1 2018 and held it in 2 quarters.
  • Two Sigma Securities's Medicines Co position peaked at $937K in Q2 2018.
  • 184 funds tracked by Wall St. Rank held Medicines Co as of Q3 2018.

Based on Two Sigma Securities's 13F filing for Q3 2018, filed 14 Nov 2018.